Articles Tagged With:
-
Initiating Contraceptive Provision with Teens
Sexuality is a natural and important part of human growth for young people and a developmental milestone. Statistics from the 2013 Youth Risk Behavior Surveillance System show that 47% of students report they ever have had sex, yet only 19% of those teens reported using birth control pills, and 5% reported using the contraceptive shot, contraceptive vaginal ring, or a long-acting reversible contraceptive method (implant or intrauterine device), at last sex.
-
In Memoriam: Ward Cates Jr., MD, MPH
Ward Cates Jr., MD, MPH, one of the co-authors of Contraceptive Technology, died March 17, 2016, in Chapel Hill, NC. Cates was president emeritus and distinguished scientist at FHI 360, a global nonprofit human development organization based in Durham, NC.
-
Do Teen LARC Users Get Message on Condom Use?
Family planning providers are seeing an increase in adolescent use of long-acting reversible contraceptive methods. Efforts to improve LARC access to adolescents seeking contraception at Title X service sites have increased their use.
-
Review reproductive health considerations for women with inflammatory bowel disease
Between 1 and 1.4 million people in the United States have inflammatory bowel disease, a group of conditions that includes Crohn’s disease and ulcerative colitis. For women of childbearing age with IBD, there are considerations related to fertility and pregnancy, according to recent information presented by the Association of Reproductive Health Professionals.
-
FDA Updates Mifepristone Labeling, Easing Access to Abortion Pill
The Food and Drug Administration has approved new and updated labeling for the medication abortion drug mifepristone (Mifeprex, Danco Laboratories, New York City) to reflect the most current clinical practices and safety and efficacy data. The drug’s new label reduces the size of the initial dose and extends the window for taking it to 70 days since the first day of a woman’s last menstrual period.
-
What’s in the Pipeline? Science Moves Long-acting Contraceptive Options Forward
With the growth in interest in long-acting reversible contraceptive methods, what new options may be available to U.S. women?
-
Zika Virus Update — What Do Your Patients Need to Know?
Approximately four in 10 (42%) U.S. adults in households in which someone is pregnant or considering becoming pregnant don’t realize the Zika virus can be sexually transmitted, according to results from a new national survey. The poll is part of an ongoing series of surveys focused on the public’s response to public health emergencies by the Harvard Opinion Research Program at the Boston-based Harvard T.H. Chan School of Public Health.
-
FDA Proposes Ban on Electrical Stimulation Devices
Agency targets a Massachusetts group home that still employs questionable behavioral treatment.
-
Lawmakers Call for Ban on Powdered Caffeine
This non-FDA approved product has produced deadly outcomes.
-
Guess Where a Doctor Hid a Camera to Try to Catch a Thief?
This doctor used his skills as an ex-TV investigative reporter, but now he is charged.